News About: Pharm. Industry
KPBMA strengthens capability in biopharmaceutical and 4th Industrial Revolution fields
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee_Mok Won, KPBMA) will carry out reorganization of its secretariat and a series of rotational personnel appointments by recruiting experts i...
What is the reason why pharmaceutical sales reps are likely to chance jobs?
As pharmaceutical companies have been working hard to reduce selling, general and administrative(SG&A) expenses to secure profitability, it was analyzed their sales were highly likely to change jobs recently.
Accordi...
Necessity of having a control tower for policy and support related to new drug development
With the goal of nurturing the Korean biopharmaceutical industry, an argument was strongly proposed that policies related to R&D support from each governmental department should be carried out to accelerate new drug d...
Cosmetic companies make KRW 11 out of selling KRW 100 in 1st quarter
Net profits made by major Korean cosmetic companies in the 1st quarter of the year were dropped compared to the same quarter of the last year, but were largely increased compared to the last quarter(4th quarter of 201...
Strict restriction on SH Pharm for providing illegal rebates
The Fair Trade Commission(Chairman Jae-Chan Jeong, hereinafter referring to FTC) decided to impose a correction order to SH Pharm(located in Busan), a pharmaceutical distribution company that provided financial benefi...
3 Huons Global-affiliated companies receives investment worth of KRW 12 billion
Huons Global(CEO Sung-Tae Yoon, Won-Sup Kim) announced on the 12th that Korea Investment Partners, the Korea’s largest venture capital, and Korea Development Bank jointly invested the total KRW 12 billion into 3 compa...
What are innovative plans of pharmaceutical industry towards Fourth Industrial Rev.?
A place will be arranged for Korea to become a global pharmaceutical power ahead of the Fourth Industrial Revolution.
The Pharmaceutical Society of Korea(President Ae-Ri Moon) and the Korea Pharmaceutical and Bio-Pha...
Janssen starts a new clinical trial as manufacturing issue is addressed
Janssen, a multinational pharmaceutical company owning the license of JNJ-64565111, a Hanmi Pharm’s biologic for the treatment of diabetes and obesity, will start a new clinical trial at the end of this year as the ‘m...
Daewha Pharmaceutical acquires S&V, German filler manufacturer
Daehwa Pharmaceutical announced acquisition of ‘S&V Technologies,’ a German filler manufacturer, on the 8th.
The company and RedoxBio, its subsidiary, signed a joint agreement of acquiring 100% of the S&V Technologie...
Kukje Pharma, Samil Pharmaceutical & Wooridul Pharmaceutical in R&D expense growth rate in 1st quarter
When it comes to this 1st quarter’s average R&D expenses growth rate compared to the same quarter of the last year, KOSPI listed pharmaceutical companies had an increase, but pharmaceutical companies in the KOSDAQ had...
